Pre-treatment with a P2Y12 antagonist before PCI in STEMI: why should we wait?

Eur Heart J. 2019 Apr 14;40(15):1211-1213. doi: 10.1093/eurheartj/ehz058.

Authors

Jeremie Abtan^{1

2}, P Gabriel Steg^{1

2

3}

Affiliations

¹ DHU (Département Hospitalo-Universitaire)-FIRE (Fibrosis, Inflammation, REmodelling), Hôpital Bichat, AP-HP (Assistance Publique-Hôpitaux de Paris), Université Paris-Diderot, Sorbonne-Paris Cité, Paris France.
² FACT (French Alliance for Cardiovascular clinical Trials), an F-CRIN network, INSERM U-1148, Paris, France.
³ NLHI, ICMS, Royal Brompton Hospital, Imperial College, London, UK.

PMID: 30851044
DOI: 10.1093/eurheartj/ehz058

No abstract available

Publication types

Comment

MeSH terms

Angioplasty
Coronary Angiography
Humans
Percutaneous Coronary Intervention*
Platelet Aggregation Inhibitors
Purinergic P2Y Receptor Antagonists
Registries
ST Elevation Myocardial Infarction*
Sweden

Substances

Platelet Aggregation Inhibitors
Purinergic P2Y Receptor Antagonists